BRIEF — Soufflé Therapeutics Announces Oversubscribed $135 Mln Series B Financing
Oct 13 (Reuters) — Soufflé Therapeutics: Soufflé Therapeutics™ Announces Oversubscribed $135 Million Series B Financing To Advance Lead Clinical Programs And Continued Pipeline Progress Soufflé Therapeutics: Financing Round Was Led By Juvia Group, Welcomes Leading Institutional Investors Tcg Crossover Management, Bb Biotech & Others (Reuters.Briefs@thomsonreuters.com;)